Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
Khan Najat | Chief R&D Commercial Officer, Director | 41 S. RIO GRANDE STREET, SALT LAKE CITY | /s/ Kyle Nelson, attorney-in-fact | 2025-08-19 | 0002020969 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RXRX | Class A Common Stock | Tax liability | -$21.4K | -3.79K | -0.53% | $5.64 | 705K | Aug 15, 2025 | Direct | F1 |
transaction | RXRX | Class A Common Stock | Sale | -$202K | -36.6K | -5.19% | $5.52 | 668K | Aug 18, 2025 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units. |
F2 | Represents shares that have been required to be sold by the Issuer to satisfy the tax withholding and remittance obligations in connection with the vesting of restricted stock units. |